Kazia Therapeutics KZIA Growth Metrics (2010-2025)

NASDAQ KZIA
$6.62 -0.33 (-4.75%)
At close: Nov 13, 2026 · 4:00 PM EST
Reported Financials

Kazia Therapeutics Quarterly Growth Metrics

Periods 34 quarters
Latest Dec 2025

Kazia Therapeutics reported asset growth of 25.18% for the quarter ended Dec 2025. These growth metrics cover 34 quarters of results from Jun 2010 through Dec 2025, standardized by Business Quant from the company’s SEC filings.

Growth MetricsGrowth Jun2010 Dec2010 Jun2011 Dec2011 Jun2012 Oct2012 Dec2012 Jun2013 Dec2013 Jun2014 Oct2014 Dec2014 Jun2015 Dec2015 Jun2016 Dec2016 Jun2017 Dec2017 Jun2018 Dec2018 Jun2019 Dec2019 Jun2020 Dec2020 Jun2021 Dec2021 Jun2022 Dec2022 Jun2023 Dec2023 Jun2024 Dec2024 Jun2025 Dec2025
Growth Ratios
Total Debt (QoQ)
Total Debt Growth (5y)
-45.76%156.72%
Total Debt Growth (3y)
22.29%194.70%
Total Debt Growth (1y)
443.24%1,536.56%-31.26%-67.71%-51.02%384.25%
Share-based Compensation Growth (1y)Stock Comp. Growth (1y)
60.59%
Revenue Growth (3y)
Revenue Growth (1y)
Return on Sales [ROS] Growth (3y)ROS Growth (3y)
Return on Sales [ROS] Growth (1y)ROS Growth (1y)
Return on Equity [ROE] Growth (5y)ROE Growth (5y)
-0.04M
Return on Equity [ROE] Growth (3y)ROE Growth (3y)
-0.02M
Return on Equity [ROE] Growth (1y)ROE Growth (1y)
-0.01M
Return on Capital Employed [ROCE] Growth (5y)ROCE Growth (5y)
-0.02M
Return on Capital Employed [ROCE] Growth (3y)ROCE Growth (3y)
-0.01M
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y)
0.00M
Return on Assets [ROA] Growth (5y)ROA Growth (5y)
-0.02M
Return on Assets [ROA] Growth (3y)ROA Growth (3y)
-0.01M
Return on Assets [ROA] Growth (1y)ROA Growth (1y)
0.00M
Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ)
Property, Plant & Equipment (Net) Growth (5y)PP&E (Net) Growth (5y)
43.91%39.33%69.28%68.57%-41.94%-41.97%
Property, Plant & Equipment (Net) Growth (3y)PP&E (Net) Growth (3y)
241.15%115.08%208.45%221.83%-77.59%-62.91%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y)
577.54%671.13%-14.84%258.62%-99.80%-99.82%
Net Margin Growth (3y)
Net Margin Growth (1y)
Net Income towards Common Stockholders Growth (5y)Net Income Growth (5y)
-21.09%
Net Income towards Common Stockholders Growth (3y)Net Income Growth (3y)
-47.62%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y)
-73.41%
Net Income Growth (5y)
-21.09%
Net Income Growth (3y)
-132.20%
Net Income Growth (1y)
-73.41%
Net Cash Flow Growth (1y)NCF Growth (1y)
-379.74%
Income After Tax Growth (5y)
-21.09%
Income After Tax Growth (3y)
-86.79%
Income After Tax Growth (1y)
-73.41%
Free Cash Flow Growth (1y)FCF Growth (1y)
-379.74%
FCF Margin Growth (1y)
EPS (Diluted) Growth (5y)
-16.48%
EPS (Diluted) Growth (3y)
4.79%
EPS (Diluted) Growth (1y)
3.27%
EPS (Basic) Growth (5y)
-16.48%
EPS (Basic) Growth (3y)
4.79%
EPS (Basic) Growth (1y)
3.27%
EBT Margin Growth (3y)
EBT Margin Growth (1y)
EBT Growth (5y)
-21.09%
EBT Growth (3y)
-86.79%
EBT Growth (1y)
-73.41%
EBIT Margin Growth (3y)
EBIT Margin Growth (1y)
EBIT Growth (5y)
-21.09%
EBIT Growth (3y)
-86.79%
EBIT Growth (1y)
-73.41%
EBITDA Margin Growth (3y)
Dividends payables Growth (1y)
Cash from Operations Growth (1y)Cash from Ops. Growth (1y)
-379.74%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ)
Cash & Equivalents Growth (5y)Cash & Equiv. Growth (5y)
31.18%15.41%5.81%5.37%11.48%11.43%10.06%13.19%-29.28%-26.92%-3.67%18.04%-14.54%-23.40%-4.54%-10.33%-21.95%-12.91%-13.97%47.17%
Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y)
114.23%25.30%67.68%76.54%-49.53%-49.37%-46.60%-7.49%-18.46%-15.74%67.95%37.93%9.99%-7.92%-16.79%-28.80%-62.39%-44.27%-17.55%150.19%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y)
-26.60%-85.14%-55.54%134.49%-60.61%-62.76%-13.02%-9.33%58.24%77.13%244.17%63.40%-75.57%-73.02%-31.50%-18.13%-68.23%-21.63%157.50%2,340.94%
Assets (QoQ)
Assets Growth (5y)
14.54%9.71%24.90%24.55%31.15%28.59%27.58%31.20%-14.85%-12.00%10.23%4.51%-2.20%-2.80%-2.13%1.23%-0.65%-1.97%-24.23%21.85%
Assets Growth (3y)
71.31%74.74%84.59%94.33%-16.38%-18.75%-17.92%-18.47%-16.88%-14.11%28.23%23.67%18.52%17.87%5.46%2.63%-30.97%-26.71%-45.68%25.18%
Assets Growth (1y)
-24.23%-18.60%2.88%2.30%-25.00%-35.58%-28.34%-17.77%6.86%19.61%175.39%92.32%-43.42%-28.80%-24.71%-21.05%-22.78%-29.97%-72.42%254.77%

Kazia Therapeutics Growth Metrics API

Pull Kazia Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=KZIA&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY